ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Starpharma Signs Second Oncology Agreement with AstraZeneca americanpharmaceuticalreview
June 06, 2019Starpharma announced a Development and Option Agreement with AstraZeneca to progress the development of a Dendrimer Enhanced Product (DEP?) version of an undisclosed AstraZeneca major marketed oncology medicine.
Pharma Sources Insight January 2025
